ASCENDIS PHARMA A/S - ADR (ASND) Institutional Shareholders
ASCENDIS PHARMA A/S - ADR (ASND) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $11.95B in ASND holdings during the latest filing period.
Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of ASND tracked by InsiderSet, reporting ownership valued at approximately $2.35B in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.51B, representing an estimated gain of +6.64% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 70% of the total disclosed ASND value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Avoro Capital Advisors Llc, Westfield Capital Management Co Lp, and several other long-term asset managers with concentrated positions in ASCENDIS PHARMA A/S - ADR (ASND).
This page ranks the largest institutional ASND shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
210
Total Reported Value
$11.95B
Largest Holder
Ra Capital Management, L.P.
Largest Position
$2.35B
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
91
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 24.92% | 10,281,496 | $2,351,686,580 | $2,507,759,689 | +$156,073,109 | +6.64% | |
| Avoro Capital Advisors Llc | 11.41% | 5,062,500 | $1,157,945,625 | $1,234,794,375 | +$76,848,750 | +6.64% | |
| Westfield Capital Management Co Lp | 4.62% | 4,813,440 | $1,100,978,089 | $1,174,046,150 | +$73,068,061 | +6.64% | |
| Fmr Llc | 0.05% | 3,876,601 | $886,694,943 | $945,541,750 | +$58,846,807 | +6.64% | |
| Artisan Partners Limited Partnership | 1.21% | 3,230,188 | $738,840,836 | $787,875,155 | +$49,034,319 | +6.64% | |
| Franklin Resources Inc | 0.11% | 2,051,948 | $469,341,976 | $500,490,637 | +$31,148,661 | +6.64% | |
| Capital International Investors | 0.11% | 1,958,843 | $448,046,159 | $477,781,396 | +$29,735,237 | +6.64% | |
| Massachusetts Financial Services Co | 0.14% | 1,860,669 | $425,574,778 | $453,835,776 | +$28,260,998 | +6.64% | |
| Wellington Management Group Llp | 0.08% | 1,757,633 | $402,023,397 | $428,704,265 | +$26,680,868 | +6.64% | |
| Perceptive Advisors Llc | 6.93% | 1,531,421 | $350,281,925 | $373,528,896 | +$23,246,971 | +6.64% | |
| American Century Companies Inc | 0.16% | 1,397,119 | $319,564,431 | $340,771,295 | +$21,206,864 | +6.64% | |
| Capital World Investors | 0.03% | 900,517 | $205,975,253 | $219,645,101 | +$13,669,848 | +6.64% | |
| Principal Financial Group Inc | 0.11% | 896,397 | $205,032,887 | $218,640,192 | +$13,607,305 | +6.64% | |
| Blackrock, Inc. | 0.00% | 661,054 | $151,202,889 | $161,237,681 | +$10,034,792 | +6.64% | |
| Polar Capital Holdings Plc | 0.65% | 651,712 | $149,066,086 | $158,959,074 | +$9,892,988 | +6.64% | |
| Morgan Stanley | 0.01% | 606,348 | $138,690,183 | $147,894,341 | +$9,204,158 | +6.64% | |
| Goldman Sachs Group Inc | 0.02% | 566,192 | $129,505,096 | $138,099,891 | +$8,594,795 | +6.64% | |
| Nomura Asset Management International Inc. | 0.22% | 556,427 | $127,272,000 | $135,718,110 | +$8,446,110 | +6.64% | |
| Ameriprise Financial Inc | 0.03% | 476,466 | $108,982,068 | $116,214,822 | +$7,232,754 | +6.64% | |
| Fil Ltd | 0.08% | 447,421 | $102,338,605 | $109,130,456 | +$6,791,851 | +6.64% | |
| Vestal Point Capital, Lp | 2.40% | 375,000 | $85,773,750 | $91,466,250 | +$5,692,500 | +6.64% | |
| Invesco Ltd. | 0.01% | 362,109 | $82,825,192 | $88,322,006 | +$5,496,814 | +6.64% | |
| Sei Investments Co | 0.07% | 351,146 | $80,317,658 | $85,648,021 | +$5,330,363 | +6.64% | |
| Bnp Paribas Financial Markets | 0.05% | 309,173 | $70,717,140 | $75,410,386 | +$4,693,246 | +6.64% | |
| Fred Alger Management, Llc | 0.31% | 304,896 | $69,738,862 | $74,367,183 | +$4,628,321 | +6.64% | |
| Alliancebernstein L.P. | 0.02% | 278,203 | $59,324,008 | $67,856,494 | +$8,532,486 | +14.38% | |
| Tri Locum Partners Lp | 8.20% | 255,332 | $58,402,088 | $62,278,028 | +$3,875,940 | +6.64% | |
| Candriam S.C.A. | 0.27% | 230,278 | $52,671,487 | $56,167,107 | +$3,495,620 | +6.64% | |
| Bank Of New York Mellon Corp | 0.01% | 228,675 | $52,304,831 | $55,776,119 | +$3,471,288 | +6.64% | |
| Two Sigma Investments, Lp | 0.04% | 220,341 | $50,398,597 | $53,743,373 | +$3,344,776 | +6.64% | |
| Td Asset Management Inc | 0.04% | 217,992 | $49,861,310 | $53,170,429 | +$3,309,119 | +6.64% | |
| Ubs Group Ag | 0.01% | 207,339 | $47,424,649 | $50,572,055 | +$3,147,406 | +6.64% | |
| Bank Of America Corp | 0.00% | 198,505 | $45,404,103 | $48,417,355 | +$3,013,252 | +6.64% | |
| Rock Springs Capital Management Lp | 2.62% | 194,000 | $44,373,620 | $47,318,540 | +$2,944,920 | +6.64% | |
| Millennium Management Llc | 0.03% | 189,027 | $43,236,146 | $46,105,576 | +$2,869,430 | +6.64% | |
| Allspring Global Investments Holdings, Llc | 0.07% | 184,224 | $42,047,286 | $44,934,076 | +$2,886,790 | +6.87% | |
| Orbimed Advisors Llc | 0.91% | 181,977 | $41,623,599 | $44,386,010 | +$2,762,411 | +6.64% | |
| Wells Fargo & Company/Mn | 0.01% | 154,199 | $35,269,937 | $37,610,678 | +$2,340,741 | +6.64% | |
| Pfm Health Sciences, Lp | 3.66% | 152,034 | $34,774,737 | $37,082,613 | +$2,307,876 | +6.64% | |
| Rice Hall James & Associates, Llc | 1.89% | 148,386 | $33,940,330 | $36,192,829 | +$2,252,499 | +6.64% | |
| Deutsche Bank Ag\ | 0.01% | 135,187 | $30,921,323 | $32,973,461 | +$2,052,138 | +6.64% | |
| Frazier Life Sciences Management, L.P. | 0.78% | 133,333 | $30,497,257 | $32,521,252 | +$2,023,995 | +6.64% | |
| Braun Stacey Associates Inc | 1.00% | 130,992 | $29,961,800 | $31,950,259 | +$1,988,459 | +6.64% | |
| Catalio Capital Management, Lp | 6.17% | 129,111 | $29,531,559 | $31,491,464 | +$1,959,905 | +6.64% | |
| Oddo Bhf Asset Management Sas | 1.16% | 128,657 | $29,427,716 | $31,380,729 | +$1,953,013 | +6.64% | |
| Silverarc Capital Management, Llc | 3.36% | 124,658 | $28,513,024 | $30,405,333 | +$1,892,309 | +6.64% | |
| Chevy Chase Trust Holdings, Llc | 0.08% | 123,467 | $28,240,608 | $30,114,836 | +$1,874,228 | +6.64% | |
| Renaissance Technologies LLC | Jim Simons | 0.04% | 117,332 | $26,837,348 | $28,618,448 | +$1,781,100 | +6.64% |
| Integral Health Asset Management, Llc | 1.39% | 115,000 | $26,303,950 | $28,049,650 | +$1,745,700 | +6.64% | |
| Voloridge Investment Management, Llc | 0.10% | 114,275 | $26,138,121 | $27,872,815 | +$1,734,694 | +6.64% |
Frequently asked questions about ASND
Who owns the most ASND stock?
The largest holders of ASND are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ASCENDIS PHARMA A/S - ADR (ASND).
Is ASND widely held by superinvestors?
Many widely followed stocks like ASND appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ASND is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.